Compelling research highlights the fundamental role of 3' RNA-seq in the understanding of diabetes
Deciphering complex cell signaling pathways can accelerate the understanding of various diseases such as diabetes. The use of 3’ RNA sequencing has played a vital role in this field, creating a demand for high-throughput solutions that afford increased accuracy, specificity and sensitivity. Developed for high-throughput 3' transcriptome NGS from ultralow amounts of RNA, our QIAseq UPX 3' Transcriptome Kit provides increased precision due to Unique Molecular Index technology and Locked Nucleic Acid-enhanced chemistry. Read how QIAseq UPX 3' Transcriptome technology, as part of QIAGEN Genomic Services, played an integral role in helping researchers develop a better understanding of diabetes through gene expression and cell signaling analysis and interpretation.
If you're interested in applying the multiple benefits of this technology to your own gene expression and pathway research, get started with a trial kit.
Join Matthew Dodson, Ph.D., from the University of Arizona and Raphael Werding, M.Sc., from QIAGEN, on Thursday, May 14, 2020, when they’ll present a live webinar on investigating the nrf2 transcriptome as a driver of arsenic-promoted type II diabetes. Register now
Call us during our office hours (Monday to Friday):
Never miss an email from Technology Networks. Click hereto add Technology Networks to your safe-sender list.
Technology Networks Limited Woodview | Bull Lane Industrial Estate | Sudbury | Suffolk | CO10 0FD | UK Email: privacy@technologynetworks.com
You received this email because you are subscribed to Technology Networks Special Offers and Promotions from Technology Networks Limited. Click to unsubscribe | View Privacy Policy